Company intelligence / Profile preview

Medicsen

Madrid, Community of Madrid, Spainmedicsen.com ↗

Ownership: Private
Development stage: Other

Overview

The Smartpatch device has completed initial prototyping with in vitro validation of ultrasound-based transdermal delivery. Safety testing was planned following recent funding rounds. The digital app for diabetes prediction has been piloted with user feedback but no peer-reviewed clinical outcomes are published yet. No commercial or late-stage clinical data reported as of June 2025.

Therapeutic areas: EndocrinologyOther
Modalities: Device (wearable drug delivery)Digital health software (predictive diabetes management app)
Industry: Therapeutic Medical Devices

Partnerships

No major pharmaceutical partnerships disclosed publicly as of June 2025. Some collaborations with hospitals and presence at industry events noted.

Beyond the preview

Go deeper on Medicsen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medicsen.

Explore the full profile